In a groundbreaking advancement in endocrine biology, researchers at the University of Pennsylvania’s School of Veterinary Medicine have successfully engineered a lab-grown organoid that precisely mimics the development and function of the human adrenal cortex. Nestled atop the kidneys, the adrenal glands—small but critically important walnut-sized endocrine organs—produce hormones essential to managing the body’s stress response and metabolism. Among these hormones, cortisol stands out as a paramount player, enabling physiological adaptation to a diverse range of stressors, from infection to emotional trauma. Yet, despite decades of study, the intricacies of adrenal gland formation and function have largely remained elusive, hampering efforts to develop targeted therapies for adrenal-related disorders.
Led by Kotaro Sasaki and Michinori Mayama, the research team employed a sophisticated, stepwise approach to grow an organoid from human-induced pluripotent stem cells (iPSCs) that faithfully recapitulates the prenatal functional zonation dynamics of the adrenal cortex. Unlike prior models that fell short of replicating the gland’s complex organizational hierarchy and cortisol-producing capability, this novel organoid self-organizes into a layered, three-dimensional structure exhibiting key characteristics of the developing gland. This model not only provides unprecedented access to a normally inaccessible tissue but also demonstrates functional responsiveness by producing cortisol and androgens in reaction to adrenocorticotropic hormone (ACTH), the principal brain-derived regulator of adrenal hormone secretion.
The adrenal cortex’s architecture is renowned for its layered specialization, each zone generating distinct hormones that orchestrate stress adaptation, metabolism, and blood pressure regulation. Recreating this refined spatial arrangement in vitro demanded meticulous mapping of cellular interactions occurring during early human adrenal development. Central to this breakthrough was the identification of signaling cues originating from the adrenal capsule, a slender connective tissue layer previously underappreciated but shown to be essential for maintaining the progenitor cell population that gives rise to hormone-secreting cells. By integrating capsule-derived signals with progenitor populations, the researchers induced cellular self-organization, mirroring the dynamic tissue morphogenesis observed in vivo.
One of the standout features of this adrenal organoid is its functional integrity. The team demonstrated that in response to ACTH stimulation, the organoid not only synthesized cortisol but also produced androgenic steroids, showcasing a hormonal output profile comparable to that of the natural developing adrenal cortex. This functional recapitulation opens new avenues to probe the molecular mechanisms guiding adrenal responsiveness to stress and metabolic demands. As a result, scientists can systematically manipulate the system genetically or pharmacologically, shedding light on adrenal pathophysiology with a resolution impossible to achieve in human patients due to the gland’s deep anatomical location.
This innovation holds significant promise for transforming clinical approaches to primary adrenal insufficiency, a debilitating condition exemplified by Addison’s disease where cortisol production is deficient. Current management relies heavily on lifelong exogenous steroid replacement, a treatment that falls short in mimicking the natural circadian and stress-responsive hormone rhythms, often leading to adverse effects and complications. The adrenal organoid system presents a tantalizing possibility for cell replacement therapy, potentially offering a one-time curative intervention by transplanting functional adrenal tissue derived from patient iPSCs. Such a strategy could dramatically improve quality of life and prognosis for patients suffering from adrenal hormone deficiencies.
Beyond therapeutic potential, the organoid platform serves as a powerful tool for drug discovery and precision medicine. Given that adrenal disorders span a spectrum, from cortisol excess in Cushing’s syndrome to aldosterone imbalances causing hypertension, the ability to culture large numbers of these organoids allows for high-throughput screening of pharmacological agents targeting these dysfunctions. This unprecedented accessibility is expected to accelerate the development of more selective and efficacious drugs, minimizing systemic side effects inherent in current treatments.
While the current organoid model predominantly recapitulates early and mid-stage adrenal cortex development, efforts are underway to refine the system further. The team aims to faithfully reproduce the maturation process to include cells capable of producing aldosterone, a mineralocorticoid hormone fundamental to blood pressure homeostasis. Given the global burden of diseases linked to aldosterone dysregulation, such as hypertension affecting millions worldwide, advancing the organoid’s complexity would be a monumental stride toward dissecting disease mechanisms and engineering novel therapies.
Sasaki underscores the significance of the organoid beyond immediate clinical applications, emphasizing how it provides a long-sought window into human adrenal biology. Traditional studies have been stymied by the inaccessibility and limited availability of human adrenal tissue, especially during prenatal stages when critical developmental processes unfold. This platform enables researchers to observe and manipulate adrenal development and function in real-time, enhancing understanding at molecular and cellular levels, which has remained a poorly charted frontier in endocrinology.
Moreover, the organoid system offers a unique model to study the intricate endocrine interplay regulating stress responses. Cortisol’s role as the quintessential “stress hormone” is multifaceted, influencing immune function, metabolism, and neurological processes. The capacity to decipher how adrenal cells integrate systemic signals and modulate hormone synthesis promises to unravel complex feedback loops involved in stress adaptation, potentially illuminating new pathways implicated in stress-related disorders, including depression and post-traumatic stress disorder.
Importantly, this research exemplifies the cutting-edge convergence of stem cell biology, tissue engineering, and endocrinology, highlighting the power of pluripotent stem cells as a versatile resource. By harnessing the intrinsic developmental programs within iPSCs, researchers are pioneering innovative models emulating human organogenesis and physiology. These advances lay a foundational framework not just for adrenal studies but for recapitulating other challenging tissues, fostering transformative insights and regenerative medicine solutions across multiple domains.
In conclusion, the development of a functional human adrenocortical organoid marks a pioneering milestone in understanding and treating adrenal diseases. By unlocking the developmental secrets and functional dynamics of the adrenal cortex, the system offers a dynamic platform for mechanistic studies, drug screening, and regenerative therapies that could revolutionize patient care. As research progresses to generate more mature organoids inclusive of aldosterone-producing cells, this technology stands on the cusp of reshaping how medicine addresses endocrine diseases and hormone regulation disorders in the 21st century.
Subject of Research:
Human tissue samples
Article Title:
Modeling human prenatal adrenocortical functional zonation dynamics from pluripotent stem cells
News Publication Date:
5-Mar-2026
Web References:
DOI: 10.1016/j.stem.2026.02.002 (http://dx.doi.org/10.1016/j.stem.2026.02.002)
References:
Sasaki, K., Mayama, M., Leu, A. N., Sato, T., Whelan, E. C., Strauss, J. F. III, Auchus, R. J., & Stouffer, D. G. (2026). Modeling human prenatal adrenocortical functional zonation dynamics from pluripotent stem cells. Cell Stem Cell.
Image Credits:
Michinori Mayama
Keywords:
Adrenal glands, cortisol, stress hormone, adrenal cortex, organoids, human induced pluripotent stem cells, endocrine diseases, steroid hormones, developmental biology, adrenal insufficiency, regenerative therapy, drug discovery
